Lantern Pharma Inc.

NASDAQ:LTRN

3.42 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -4.506-4.96-5.441-4.186-3.161-4.746-3.868-3.381-2.265-4.492-4.122-3.54-4.054-2.316-2.452-2.896-1.701-0.833-0.477-0.675-0.67-0.629-0.454
Depreciation & Amortization -0.0380.0460.0040.0440.0040.0040.0030.0030.0030.0020.0020.0020.0020.0020.0010.0010.0010.0010.0010.001000
Deferred Income Tax 0000.180.0950.0390000.3120.2250.2070.0150000000000
Stock Based Compensation 0.1790.1340.1340.1510.1910.3920.3340.330.3010.290.2670.2460.2240.2460.2461.0250.0440.1050.0180.0630.0330.0060.016
Change In Working Capital -1.829-0.3022.1310.879-0.780.679-0.240.38-2.3751.120.2640.977-0.8670.4290.0610.302-1.2330.237-0.245-0.0980.0860.180.013
Accounts Receivables 00000000000000000000000
Change In Inventory 00000000000000000000000
Change In Accounts Payables -1.0330.6611.2710.42-0.7680.179-0.067-3.024-2.1382.2810.7431.488-0.5430.5140.16400000000
Other Working Capital 0.103-0.9630.860.459-0.0120.50.0673.404-0.238-1.162-0.479-0.439-0.324-0.085-0.1030.001-0.0020-0.245-000-0
Other Non Cash Items 0.611-0.544-1.025-0.4540.040.040.014-0.0010.2980.0360.0360.2760.012-0.0850.084-000-00000
Operating Cash Flow -5.582-5.191-3.069-3.385-3.612-3.592-3.757-2.669-4.038-2.733-3.328-2.039-4.683-1.725-2.144-1.568-2.89-0.491-0.703-0.709-0.55-0.444-0.426
Investing Activities:
Investments In Property Plant And Equipment -0.003-0.004-0.002-0.005-0.0050-0.009-0.007-0.007-0.0140-0-0.003-0.0120-0.005-0.003-000-000
Acquisitions Net 000-0-00-2.15-179.26802.0190000000000000
Purchases Of Investments -3.117-8.348-6.012-1.555-0.731-2.807-3.102-0.59-1.318-2.0050-0.298-0.999-18.282000000000
Sales Maturities Of Investments -13.6088.155.4581.8170.9682.352.151.21.251.4930.1770.06400000000000
Other Investing Activites 17.408-0-0.00100-02.15179.268-0-2.01900.064-0.003-0.0180-16.1340000000
Investing Cash Flow 0.68-0.202-0.5560.2560.232-0.457-0.9610.603-0.074-0.5260.177-0.234-1.003-18.2940-0.005-0.003-000-0.00600
Financing Activities:
Debt Repayment 000000000000000-0.169-0.103-0.053-0.0130000
Common Stock Issued -0.05500.05500000000.30.0670-064.28900.052000000
Common Stock Repurchased 000-0.50002.48200-0.002-0.940-0000000000
Dividends Paid 00000000000000000000000
Other Financing Activities 0.06700-499.306000-2,180.316000-0.8730064.289-0-023.7160.11800.00100.002
Financing Cash Flow 0.01200.055-0.50-0.6910-2,177.83300-0.002-0.8730-064.289-0-0.10323.6630.10501.07101.85
Other Information:
Effect Of Forex Changes On Cash 0.0160.011-0.01-0.005-0.012-0.006-0.0050.010.008-0.030.002000000000000
Net Change In Cash -4.874-5.381-3.58-3.634-3.393-4.056-4.723-2.056-4.105-3.289-5.331-3.145-5.685-20.0262.144-1.573-2.99623.164-0.598-0.7090.515-0.4441.424
Cash At End Of Period 8.10312.97718.35821.93825.57228.96433.0237.74339.79943.90447.19352.52455.66961.35481.37419.22920.80323.7980.6341.2321.9411.4261.87